Training patients to self administer sub-cutaneous methotrexate (SCMTX)

Training patients to self administer sub-cutaneous methotrexate (SCMTX)

Bibliographic Details
Main Authors:	White, C, Lindsay, G, Livingstone, J, Luqmani, R
Format:	Journal article
Published:	2001

Similar Items

Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience
by: Demary W, et al.
Published: (2014-08-01)

Methotrexate-induced nonhealing cutaneous ulcers in a nonpsoriatic patient without pancytopenia
by: Venkatesh Krishnamurthy Tekur
Published: (2016-01-01)

The efficacy and safety of methotrexate versus interferon in cutaneous T-cell lymphomas
by: Thevaki Wain, et al.
Published: (2018-10-01)

Higher Odds of Adverse Cutaneous Reactions in Patients With Dermatomyositis Treated With Hydroxychloroquine Compared With Methotrexate
by: Astia Allenzara, et al.
Published: (2023-11-01)

Self-administered at-home lung ultrasound with remote guidance in patients without clinical training
by: Nika Elmi, et al.
Published: (2024-03-01)

Cutaneous Eruption after SARS-CoV-2 vaccine in psoriatic patient treated with methotrexate
by: Lembo Serena, et al.
Published: (2022-01-01)

Administering self-concept interventions in schools: No training necessary? A meta-analysis
by: O'Mara, A, et al.
Published: (2006)

Early clinical indicators of acute kidney injury caused by administering high-dose methotrexate therapy to juvenile pigs
by: Randal K. Buddington, et al.
Published: (2023-09-01)

Developing and administering : an industrial training program/
by: 209871 Dowling, John R., et al.
Published: (1979)

Comparison of the self-administered and interviewer-administered modes of the child-OIDP
by: O'Brien Kevin, et al.
Published: (2008-06-01)

Treatment-refractory cutaneous Rosai–Dorfman disease responsive to oral methotrexate and topical trametinib
by: Christopher J. Fay, BA, et al.
Published: (2023-09-01)

Evaluation of a self-administered oral glucose tolerance test.
by: Bethel, M, et al.
Published: (2013)

EFFICACY OF FUROSEMIDE IN METHOTREXATE CLEARANCE IN PATIENTS TREATED WITH HIGH DOSE METHOTREXATE
by: Saqib Khan, et al.
Published: (2022-10-01)

A self-configuring and self-administering name system
by: Feng, Michael L. (Michael Lung-Kai), 1978-
Published: (2014)

An overview of self-administered health literacy instruments
by: O Neill, B, et al.
Published: (2014)

Cutaneous Methotrexate-Related Epstein–Barr Virus-Positive Diffuse Large B-Cell Lymphoma in a Patient with Granulomatous Cutaneous T-Cell Lymphoma: A Case Report and Literature Review
by: Kositkuljorn C, et al.
Published: (2023-08-01)

Fournier's gangrene that initially mimicked pubic cellulitis in an elderly woman administered a Janus kinase inhibitor, methotrexate, and prednisolone for rheumatoid arthritis
by: Takahiro Shiratori, et al.
Published: (2020-06-01)

A self-administered questionnaire for assessment of symptoms and function of the shoulder.
by: Dawson, J, et al.
Published: (1998)

Methotrexate
by: Nilgün Şentürk
Published: (2022-04-01)

Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient
by: Gabriella Guarnieri, et al.
Published: (2022-02-01)

Validity of the self-administered comorbidity questionnaire in patients with inflammatory bowel disease
by: Reinier Cornelis Anthonius van Linschoten, et al.
Published: (2023-10-01)

A disposable, self-administered electrolyte test
by: Prince, Ryan, 1977-
Published: (2005)

Nano Methotrexate versus Methotrexate in Targeting Rheumatoid Arthritis
by: Heba F. Salem, et al.
Published: (2022-12-01)

Administering the training program 6014D [electronic resource]

Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis.
by: Moore, R, et al.
Published: (1996)

Reminder packaging for improving adherence to self-administered long-term medications.
by: Heneghan, C, et al.
Published: (2006)

Methotrexate for refractory adult atopic dermatitis leads to alterations in cutaneous IL-31 and IL-31RA expression
by: Luciana Paula Samorano, et al.
Published: (2024-01-01)

Methotrexate-induced cutaneous lymphoproliferative disorders presenting as Epstein-Barr virus-positive mucocutaneous ulcer mimicking high-grade lymphoma
by: Macklin, P, et al.
Published: (2022)

Cutaneous Management after Extravasation of High-Concentrated Amino Acid Solution Administered for Renal Protection in PRRT
by: Chaninart Sakulpisuti, et al.
Published: (2022-02-01)

HERPES ZOSTER IN RA PATIENT TREATED WITH METHOTREXATE
by: Yu. V. Muraviev, et al.
Published: (2022-05-01)

Reminder packaging for improving adherence to self-administered long-term medications.
by: Mahtani, K, et al.
Published: (2011)

Atopic Dermatitis Patients’ Preference on Patient Self-administered Tools Used in Clinical Practice
by: Johanna M. Mandelin, et al.
Published: (2023-04-01)

Evaluation of a self-administered oral glucose tolerance test
by: Bethel, M, et al.
Published: (2013)

Methotrexate (MTX) failed to control giant cell arteritis (GCA)
by: Hoffman, G, et al.
Published: (2001)

Concordance of care processes between medical records and patient self-administered questionnaires
by: Cynthia Khanji, et al.
Published: (2019-07-01)

Analysis of patient and nurse preferences for self-administered FSH injection devices in select European markets
by: Zitoun P, et al.
Published: (2019-01-01)

Methotrexate in a psoriatic arthritis patient
by: K. V. Aleksanyan, et al.
Published: (2022-12-01)

Cutaneous manifestations of ANCA-associated vasculitis
by: Chiesafuxench, Z, et al.
Published: (2016)

Abatacept with methotrexate versus other biologic agents in treatment of patients with active rheumatoid arthritis despite methotrexate: a network meta-analysis.
by: Guyot, P, et al.
Published: (2011)

Self-Administered Questionnaire to Screen for Polycystic Ovarian Syndrome
by: Bronwyn S. Bedrick, et al.
Published: (2020-12-01)